Stay updated on Pembrolizumab and Radiotherapy in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Radiotherapy in NSCLC Clinical Trial page.

Latest updates to the Pembrolizumab and Radiotherapy in NSCLC Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedNew help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study). The Study Plan header formatting changed from 'Intervention / Treatment' to 'Intervention/Treatment', the recruitment status was updated to 'No longer looking for participants', and a site revision tag 'v3.6.0' indicates a recent update.SummaryDifference0.4%

- Check18 days agoChange DetectedThe page shows a revision label updated from v3.5.4 to v3.5.5, indicating a new iteration of the page's content or layout. No study details or results are changed.SummaryDifference0.1%

- Check39 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4, indicating a small update to the page's versioning. There are no visible changes to the study data, eligibility criteria, or outcomes on the page.SummaryDifference0.1%

- Check61 days agoChange DetectedThe page is updated to reflect a new ClinicalTrials.gov interface/release revision number (from v3.5.2 to v3.5.3). This represents a site maintenance/version change rather than a change to the underlying study information.SummaryDifference0.1%

- Check68 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check97 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab and Radiotherapy in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Radiotherapy in NSCLC Clinical Trial page.